Dr. Agarwals Eye Hospital posts Q3 FY24 PAT at Rs. 9.44 Cr

The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023

Pharmatech Associates adds Dr. Praveen Tyle to Board of Trustees

Parexel collaborates with Japanese Foundation for cancer research

Collaboration streamlines patient access to oncology clinical trials

CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'

Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer

Apollo Hospital Seshadripuram partners with LifeSigns

Inducts advanced AI-Powered 24x7 remote patient monitoring system

Ayush gets big boost in the North East

India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid

Ayush Minister Sonowal to lay foundation stone of Regional Research Institute for Homoeopathy at Guwahati

The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic

Hikal invests Rs. 500 crore into fine chemicals plant at Panoli

Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit

GSK to acquire Aiolos Bio for US$ 1 billion upfront payment

Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway

European Commission approves Pfizer’s Talzenna in combination with Xtandi for treatment of metastatic castration-resistant prostate cancer

TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union